Saturday 17 October 2026 Export ETON’s income statement to Excel — free account

Eton Pharmaceuticals, Inc.

ETON Healthcare Drug Manufacturers Specialty & Generic

Eton Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $80.0 million, up 104.9% from fiscal 2024. In the quarter to June 2026, revenue grew 98.6%, EPS grew 520.0%, free cash flow fell 8.78% and total debt fell 7.54%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

50.40 0.93 −1.81%

Follow ETON

Alert me

Market cap: $1.5B
P/E: 107×
Fwd P/E: 40.3×
Dividend yield: —
F-score: 5/9
Altman Z: 3.55
Beneish M: −2.24
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	5	5	6
ROE Full definition →		(34.17%)	(18.19%)	(5.36%)	35.97%
ROA Full definition →		(9.52%)	(5.47%)	(1.62%)	11.67%
ROIC Full definition →		(10.23%)	(1.71%)	3.06%	21.39%
Return on Tangible Assets Full definition →		(23.77%)	(20.52%)	(15.63%)	53.25%
Average Days of Receivables Full definition →		67.91	53.67	56.29	86.02
Free Cash Flow per Share Full definition →		0.78	0.38	(0.28)	(0.30)
Free Cash Flow Full definition →		21.01	10.18	(7.70)	(8.39)
Capital Expenditures Full definition →		(0.30)	(0.34)	(23.54)	(23.52)
Other line items
Cash ROIC Full definition →		23.19%	12.32%	(9.50%)	(8.28%)
Accounts Receivable Turnover Full definition →		7.53	9.34	5.83	5.37
Accounts Payable Turnover Full definition →		4.04	4.91	4.28	3.35
Inventory Turnover Full definition →		3.64	2.43	2.80	2.62
Average Days of Payables Full definition →		152.18	107.67	125.18	118.17
Days of Inventory on Hand Full definition →		179.89	151.25	134.29	83.21
Tax Rate Full definition →		0.03	0.01	(0.01)	0.00
Research and Development Expense of Revenue Full definition →		7.27%	9.71%	9.75%	5.45%
Selling, General and Administrative Expense of Revenue Full definition →		47.90%	44.80%	42.67%	36.97%
Share Based Compensation of Revenue Full definition →		7.35%	6.89%	6.71%	4.93%
Interest Coverage Full definition →		(1.00)	—	0.58	4.59
Operating CF/Net income Full definition →		(3.19)	(2.29)	(10.74)	1.19
Depreciation/Fixed assets Full definition →		16.81	14.54	12.59	14.70
Capex/Depreciation Full definition →		(0.06)	(0.07)	(5.03)	(4.55)
Revenue per Share Full definition →		2.61	2.97	3.19	3.82
Operating CF per Share Full definition →		0.79	0.39	0.58	0.55
Capex per Share Full definition →		(0.01)	(0.01)	(0.86)	(0.85)
Capex to Sales Full definition →		0.00	0.00	0.27	0.22

Show all line items

Columns are period end dates

Stockrow Weekly